1. Dr. Marc Lippman. Breast Cancer hormone therapy expert. Biography. 0

Dr. Marc Lippman, MD, explains the evolution of endocrine treatment. He is a professor of oncology and medicine at Georgetown University.

2. Hormone therapy for breast cancer. History and advances. 1

Dr. Marc Lippman, MD, explains the history and current state of endocrine treatments. He details how hormone-dependent breast cancer was first observed centuries ago.

3. How to prevent 70% of breast cancers? Tamoxifen. Aromatase inhibitors. 2

Dr. Marc Lippman, MD, explains how anti-hormonal therapies can prevent up to 70% of breast cancers. He details the profound impact of estrogen exposure duration...

4. Test How to prevent 70% of breast cancers? Tamoxifen. Aromatase inhibitors. 2

5. Breast cancer hormone therapy. Tamoxifen vs. Anastrozole? 3

Dr. Marc Lippman, MD, explains the choice between Tamoxifen and aromatase inhibitors like anastrozole. He details the specific use cases for each medication based on...

6. Breast cancer hormone therapy. LHRH agonists. Tamoxifen. SERDs. Aromatase inhibitors. SERMs. 4

Dr. Marc Lippman, MD, explains the major classes of endocrine medications. He details the use of LHRH agonists, SERMs, SERDs, and aromatase inhibitors.

7. When can breast cancer be considered cured? Is cure possible for breast cancer? 5

Dr. Marc Lippman, MD, explains the concept of cure in oncology. He clarifies that the five-year disease-free milestone is not a universal standard for cure....

8. Breast cancer hormone therapy. 5 or 10 years for Aromatase inhibitors? Estrogens promote breast cancer. 6

Dr. Marc Lippman, MD, explains the complex roles of estrogens and progestins in breast cancer development. He details how estrogens act as promoters of cancer...

9. Breast cancer hormone therapy. Opposing progestins to prevent or treat breast cancer? 7

Dr. Marc Lippman, MD, explains the complex role of progestins and anti-progestins in breast cancer treatment. He details the clinical and political challenges surrounding anti-progestin...

10. Breast cancer hormone therapy. How to choose aromatase inhibitors? 8

Dr. Marc Lippman, MD, explains how to choose aromatase inhibitors. He details the lack of clinical difference between steroidal and non-steroidal types.

11. Breast cancer hormone therapy. LHRH agonists or bilateral salpingo-oophorectomy (BSO)? 9

Dr. Marc Lippman, MD, explains ovarian suppression methods for premenopausal patients. He details the choice between LHRH agonists and bilateral salpingo-oophorectomy (BSO).

12. Breast cancer treatment. How to select neoadjuvant and adjuvant chemotherapy? 10

Dr. Marc Lippman, MD, explains the selection of neoadjuvant and adjuvant chemotherapy protocols. He details the significant advantages of administering systemic therapy before surgery.

13. Immunotherapy in breast cancer. Immunotherapy is not a magic treatment. 11

Dr. Marc Lippman, MD, explains the current state and limitations of immune checkpoint inhibitors in breast cancer treatment. He details the qualitative differences in response...